Indeed, the use of OX40 agonists with ICIs, cytokines such as IL2 and IL12, chemotherapeutic drugs such as cyclophosphamide, or radiation therapy, has shown a synergic effect on different types of murine cancer[68, 71, 72]. The gene discussed is TNFRSF4; the disease is cancer.